Publications by authors named "F A Barada"
Limited access to support services due to language and cultural barriers often results in a belief that family alone is the only option during times of need among Arab Americans. We test whether participation in a culturally adapted version of the Alzheimer's Association "Living with Alzheimer's" educational program is associated with positive outcomes for Arab-American care partners ( = 58). We present a single group design using paired t-tests that demonstrate reduced care burden and increased care satisfaction from pre- to post-participation.
View Article and Find Full Text PDFRecent and anticipated novel drug approvals (3Q 2024 through 2Q 2025).
Am J Health Syst Pharm
November 2024
Article Synopsis
- AJHP is posting accepted manuscripts online promptly to speed up publication, even before final formatting and author proofing are completed.
- The article highlights the essential role of health-system pharmacists in managing drug formularies and resources, focusing on upcoming drug approvals that could impact clinical practices.
- Anticipated drug approvals include new treatments for various cancers and rare diseases, with several innovative therapies and delivery methods under review by the FDA for the period of late 2024 to mid-2025.
Recent and anticipated novel drug approvals (Q2 2024 through Q1 2025).
Am J Health Syst Pharm
August 2024
Article Synopsis
- Health-system pharmacists are vital for managing drug formularies and clinical programs, and this article provides updates on upcoming drug approvals to aid their work.
- The article reviews drug approvals expected between Q2 2024 and Q1 2025, focusing on those that may significantly impact healthcare settings and are awaiting FDA approval.
- New therapies are being developed for cancers and rare diseases, alongside drugs addressing conditions like diabetes and chronic obstructive pulmonary disease.
Purpose: Health-system pharmacists play a crucial role in monitoring the pharmaceutical pipeline to manage formularies, allocate resources, and optimize clinical programs for new therapies. This article aims to support pharmacists by providing periodic updates on new and anticipated novel drug approvals.
Summary: Selected drug approvals anticipated in the 12-month period covering the first quarter of 2024 through the fourth quarter of 2024 are reviewed.
Purpose: Health-system pharmacists play a crucial role in monitoring the pharmaceutical pipeline to manage formularies, allocate resources, and optimize clinical programs for new therapies. This article aims to support pharmacists by providing updates on new and anticipated novel drug approvals.
Summary: Selected drug approvals anticipated in the 12-month period covering the fourth quarter of 2023 through the third quarter of 2024 are reviewed.